The Importance of Extended High Frequencies in Hearing Evaluation of Pediatric Patients with Type 1 Diabetes

Selis Gülseven Güven1, Çiğdem Binay2

  • 1Çorlu State Hospital, Tekirdağ; Trakya University Faculty of Medicine, Department of Otorhinolaryngology, Clinic of Head and Neck Surgery, Edirne, Turkey

Insights

Children with type 1 diabetes (T1D) may have early signs of hearing loss, even without symptoms. Extended high-frequency (EHF) audiometry can detect subclinical hearing issues in diabetic children, prompting closer glucose monitoring.

Area of Science:

  • Pediatrics
  • Otolaryngology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) is a common childhood disease with potential systemic effects.
  • Diabetes can lead to progressive sensorineural hearing loss, typically affecting high frequencies.
  • Subclinical hearing loss in children with T1D may serve as an early indicator.

Purpose of the Study:

  • To investigate extended high-frequency (EHF) hearing sensitivity in children with T1D.
  • To identify EHF audiometry as an early marker for hearing loss in the conventional range.
  • To assess the relationship between T1D and early-onset hearing impairment.

Main Methods:

  • A case-control study involving 42 children (21 with T1D, 21 controls).
  • Conventional and EHF (14,000–18,000 Hz) audiometry were performed.
  • Blood biochemistry and HbA1c levels were measured in the diabetes group; data analyzed using statistical tests and logistic regression.

Main Results:

  • Children with T1D had significantly higher mean hearing thresholds than controls at conventional frequencies (500–8,000 Hz).
  • A higher number of ears in the T1D group showed elevated thresholds at EHF (14,000–18,000 Hz) compared to controls.
  • Hearing thresholds were normal in the conventional range but elevated in the EHF range for children with T1D.

Conclusions:

  • Children with T1D exhibit elevated hearing thresholds in the EHF range despite normal conventional hearing.
  • EHF audiometry is a potentially effective tool for detecting subclinical hearing loss in diabetic children.
  • Close blood glucose monitoring is recommended for diabetic children with elevated EHF hearing thresholds to prevent conventional hearing loss.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
648
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
328